中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents

文献类型:期刊论文

作者Asrorov, Akmal M.4,5,6; Muhitdinov, Bahtiyor5,6; Tu, Bin6; Mirzaakhmedov, Sharafitdin5; Wang, Huiyuan6; Huang, Yongzhuo1,2,3,6
刊名MOLECULES
出版日期2022-06-01
卷号27期号:12页码:35
关键词enzyme drugs cancer therapy trichosanthin gelonin peroxidase glucose oxidase asparaginase exotoxin diphtheria toxin
DOI10.3390/molecules27123836
通讯作者Wang, Huiyuan(wanghuiyuan@simm.ac.cn) ; Huang, Yongzhuo(yzhuang@simm.ac.cn)
英文摘要Cancer is one of the most serious human diseases, causing millions of deaths worldwide annually, and, therefore, it is one of the most investigated research disciplines. Developing efficient anticancer tools includes studying the effects of different natural enzymes of plant and microbial origin on tumor cells. The development of various smart delivery systems based on enzyme drugs has been conducted for more than two decades. Some of these delivery systems have been developed to the point that they have reached clinical stages, and a few have even found application in selected cancer treatments. Various biological, chemical, and physical approaches have been utilized to enhance their efficiencies by improving their delivery and targeting. In this paper, we review advanced delivery systems for enzyme drugs for use in cancer therapy. Their structure-based functions, mechanisms of action, fused forms with other peptides in terms of targeting and penetration, and other main results from in vivo and clinical studies of these advanced delivery systems are highlighted.
WOS关键词PHASE-I TRIAL ; IMMUNOTOXIN RFB4(DSFV)-PE38 BL22 ; RIBOSOME-INACTIVATING PROTEIN ; TARGETED PSEUDOMONAS EXOTOXIN ; ADVANCED SOLID TUMORS ; PTD-MODIFIED ATTEMPTS ; GROWTH-FACTOR ALPHA ; DIPHTHERIA-TOXIN ; L-ASPARAGINASE ; GLUCOSE-OXIDASE
资助项目CAS President's International Fellowship Initiative, Belt and Road Yong Scientist program ; National Key Research and Development Program of China (China)[2021YFE0103100] ; National Nature Science Foundation of China[8201101172] ; National Nature Science Foundation of China[81925035] ; National Nature Science Foundation of China[81521005] ; Shanghai Sci-Tech Innovation Initiative[19431903100] ; Shanghai Sci-Tech Innovation Initiative[18430740800] ; Sanofi-SIBS Yong Faculty Award
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
语种英语
出版者MDPI
WOS记录号WOS:000816551700001
源URL[http://119.78.100.183/handle/2S10ELR8/301806]  
专题中国科学院上海药物研究所
通讯作者Wang, Huiyuan; Huang, Yongzhuo
作者单位1.Natl Med Prod Adm, Key Lab Qual Res & Evaluat Pharmaceut Excipients, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Zhongshan 528437, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
4.Ajou Univ Tashkent, Sci Dept, Tashkent 100204, Uzbekistan
5.Uzbek Acad Sci, Inst Bioorgan Chem, Tashkent 100125, Uzbekistan
6.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Asrorov, Akmal M.,Muhitdinov, Bahtiyor,Tu, Bin,et al. Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents[J]. MOLECULES,2022,27(12):35.
APA Asrorov, Akmal M.,Muhitdinov, Bahtiyor,Tu, Bin,Mirzaakhmedov, Sharafitdin,Wang, Huiyuan,&Huang, Yongzhuo.(2022).Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.MOLECULES,27(12),35.
MLA Asrorov, Akmal M.,et al."Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents".MOLECULES 27.12(2022):35.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。